Darzalex

Pharma

FDA 'proactively' awards J&J a national priority review voucher

The FDA granted the CNPV to J&J's combination of Tecvayli and Darzalex in multiple myeloma just a few days after a detailed phase 3 data presentation.

Angus Liu Dec 15, 2025 12:33pm

ASH: J&J pressures CAR-T with Tecvayli combo in 2L myeloma

Dec 9, 2025 7:30am

FDA OKs Darzalex as 1st drug for smoldering multiple myeloma

Nov 6, 2025 4:27pm

J&J eyes earlier myeloma treatment with ph. 3 Tecvayli combo win

Oct 16, 2025 8:10am

Sanofi's Sarclisa SC, delivered by on-body injector, matches IV

Jun 3, 2025 8:15am

FDA advisors back Darzalex as treatment for early myeloma

May 21, 2025 8:52am